At the SMi Controlled Release conference in London last week, we spoke with Andrew Miller, Director of the Imperial College London Genetic Therapies Centre. Andrew is working on “soft, triggerable nanoparticles” for...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)